Biotechnology Jobs

526 jobs for “Medical Services”

Results

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - Lung

  • USA - Pennsylvania - Upper Providence
  • On-site
  • US$242,550 – US$404,250 pa
  • Director · manages people

Senior physician leader providing medical oversight, safety monitoring and clinical insight across lung cancer studies, from protocol design through data interpretation. Serves on the Clinical Matrix Team, contributes to regulatory interactions and external scientific engagement, and mentors Medical Directors within the programme. Requires deep lung cancer drug development expertise, including early phase trials.

Last month

GSK · 10000+ people · Public

Senior Medical Director, Oncology Clinical Development - GU

  • USA - Pennsylvania - Upper Providence
  • On-site
  • US$284,250 – US$473,750 pa
  • Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 interventional trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety data review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds key external expert relationships and contributes to business development diligence.

Last month

GSK · 10000+ people · Public

Director, Oncology Translational Medicine, Clinical Biomarkers

  • Baar Onyx
  • Hybrid
  • US$189,750 – US$316,250 pa
  • Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, FISH, PCR, IHC/IF, flow cytometry, liquid biopsy/ctDNA and multi-omic analyses, and oversees sample testing plans and biomarker data packages for clinical and regulatory decisions.

NGS · FISH · PCR +6

Last week

GSK · 10000+ people · Public

Director, Oncology Translational Medicine, Clinical Biomarkers

  • USA - Pennsylvania - Upper Providence
  • Hybrid
  • US$189,750 – US$316,250 pa
  • Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Validates predictive, pharmacodynamic and resistance biomarkers using platforms such as NGS, ctDNA, flow cytometry and multi-omic analyses to inform dose selection and go/no-go decisions.

IHC/IF · Liquid Biopsy · ctDNA +3

3 weeks ago

GSK · 10000+ people · Public

Director, Oncology Translational Medicine, Clinical Biomarkers

  • London
  • Hybrid
  • US$189,750 – US$316,250 pa
  • Director

Leads the design and execution of clinical biomarker and translational medicine strategies for late-stage oncology assets, defining patient segmentation and decision criteria within Clinical Matrix Teams. Oversees biomarker assay development, sample testing plans and data packages across platforms such as NGS, IHC, flow cytometry and ctDNA, working with internal and external partners.

IHC/IF · Liquid Biopsy · ctDNA +3

3 weeks ago

GSK · 10000+ people · Public

VP, Medicine Development Leader - Specialty Product Development

  • USA - Pennsylvania - Upper Providence
  • Hybrid · 2 days in office
  • US$242,250 – US$403,750 pa
  • Director · manages people

Leads the global development of a medicine from clinical Proof of Concept to approval in first major markets, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset budget and resourcing plan. Hybrid role requiring at least two days per week on-site at a US or UK GSK site.

3 months ago

GSK · 10000+ people · Public

VP, Medicine Development Leader - Specialty Product Development

  • Waltham, United States
  • Hybrid · 2 days in office
  • US$242,250 – US$403,750 pa
  • Director · manages people

Leads the global development of a medicine from clinical Proof of Concept through first major-market approval, acting as the single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, and owns the asset's strategy, budget and governance decisions.

3 months ago

GSK · 10000+ people · Public

VP, Medicine Development Leader - Specialty Product Development

  • London
  • Hybrid · 2 days in office
  • US$242,250 – US$403,750 pa
  • Director · manages people

Leads the global development of a medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and directs a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving strategy, governance and go/no-go decisions. Hybrid role with at least two days per week on-site.

3 months ago

GSK · 10000+ people · Public

VP, Medicine Development Leader, Oncology - GI

  • USA - Pennsylvania - Upper Providence
  • Hybrid · 2 days in office
  • US$266,250 – US$443,750 pa
  • Director · manages people

Strategically leads global development of an oncology medicine from clinical Proof of Concept to approval in first major markets, acting as single point of accountability. Builds and leads a matrixed Medicine Development Team spanning clinical, medical, commercial and manufacturing, driving evidence packages, governance decisions and lifecycle plans.

2 weeks ago

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • London
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Senior · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability and chairing a cross-functional matrix Medicine Development Team spanning clinical, translational, regulatory, manufacturing and commercial. Drives strategy, go/no-go decisions and lifecycle plans for novel vaccine platforms such as mRNA and neoantigen-based therapies.

mRNA · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Waltham, United States
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

mRNA · Personalized Vaccine Manufacturing · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Stevenage
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

mRNA · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

VP, Medicine Development Leader- Cancer Vaccines, Oncology Research Unit

  • Zug, Switzerland
  • Hybrid · 2 days in office
  • US$340,500 – US$567,500 pa
  • Director · manages people

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and serves as asset spokesperson to senior governance boards.

mRNA · Checkpoint Inhibitors

Last month

GSK · 10000+ people · Public

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines - Respiratory

  • London
  • Director · manages people

Leads global real-world evidence and health outcomes strategy for assigned respiratory assets, overseeing integrated evidence and data generation plans across the product lifecycle. Partners with medical, commercial, market access and external experts, HTA bodies and payers to ensure scientifically credible evidence supports reimbursement, access and value-based pricing. Includes line management and matrix leadership within the Specialty Leadership Team.

Last week

GSK · 10000+ people · Public

Senior Director, Global Real-World Evidence & Health Outcomes Research Lead, Specialty Medicines - Respiratory

  • Mississauga, Canada
  • Director · manages people

Leads global real-world evidence and health outcomes strategy for assigned respiratory assets, overseeing integrated evidence and data generation plans across the product lifecycle. Partners with medical, commercial, market access and external experts, HTA bodies and payers to shape value propositions and support reimbursement and patient access.

Last week

Get new Medical Services roles by email. One email a week when new roles match, or daily if you prefer. Stop any time.

Filters

Are you sure?